Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients.
about
CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients.Belatacept Compared to Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study.Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function.Successful Treatment of T Cell-Mediated Acute Rejection with Delayed CTLA4-Ig in Mice.Costimulation Blockade Holds Emerging Hope for Patients in Large Markets Only.T Cell Repertoire Maturation Induced by Persistent and Latent Viral Infection Is Insufficient to Induce Costimulation Blockade Resistant Organ Allograft Rejection in Mice.
P2860
Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Comparison of Utilization and ...... n Renal Transplant Recipients.
@en
Comparison of Utilization and ...... n Renal Transplant Recipients.
@nl
type
label
Comparison of Utilization and ...... n Renal Transplant Recipients.
@en
Comparison of Utilization and ...... n Renal Transplant Recipients.
@nl
prefLabel
Comparison of Utilization and ...... n Renal Transplant Recipients.
@en
Comparison of Utilization and ...... n Renal Transplant Recipients.
@nl
P2093
P2860
P356
P1476
Comparison of Utilization and ...... n Renal Transplant Recipients.
@en
P2093
P2860
P304
P356
10.1111/AJT.13853
P407
P577
2016-05-03T00:00:00Z